Deficient or abundant but unable to fight? Estimation of circulating FoxP3+ T regulatory cells and their counteracting FoxP3- in rheumatoid arthritis and correlation with disease activity

Egyptian Rheumatologist

Volumn 35, Issue 4, 2013, Pages 185-192

  Abaza, Nouran ^a   EL kabarity, Rania H ^a   Abo Shady, Rania A ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

FoxP3; Rheumatoid arthritis; T regulatory cells

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; CD4+ CD25+ FOXP3+ T REGULATORY LYMPHOCYTE; CD4+ CD25+ FOXP3- T REGULATORY LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DAS28; DISEASE ACTIVITY; DRUG TARGETING; EFFECTOR CELL; FEMALE; FLOW CYTOMETRY; HUMAN; INFLAMMATION; MALE; OBSERVATIONAL STUDY; PATHOGENESIS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REMISSION; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SUPPRESSOR CELL;

EID: 84884962513     PISSN: 11101164     EISSN: 20902433     Source Type: Journal    
DOI: 10.1016/j.ejr.2013.03.005     Document Type: Article

References (35)

1. + regulatory T cells: control of FoxP3 expression by pharmacological agents. Trends Pharmacol Sci 2011, 32:158-166.
2. Williams L.M., Rudensky A.Y. Maintenance of the FoxP3-dependent developmental program in mature regulatory T cells requires continued expression of FoxP3. Nat Immunol 2007, 8:277-284.
3. Wan Y.Y., Flavell R.A. Regulatory T-cell functions are subverted and converted owing to attenuated FoxP3 expression. Nature 2007, 445:766-770.
4. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., Yasayko S.A., et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001, 27:68-73.
5. Ochs H.D., Gambineri E., Torgerson T.R. IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity. Immunol Res 2007, 38:112-121.
6. Chehata J.C., Hassell A.B., Clarke S.A., Mattey D.L., Jones M.A., Jones P.W., et al. Mortality in rheumatoid arthritis: relationship to single and composite measures of disease activity. Rheumatology (Oxford) 2001, 40:447-452.
7. Gabriel S.E., Crowson C.S., Kremers H.M., Doran M.F., Turesson C., O'Fallon W.M., et al. Survival in rheumatoid arthritis: a population-based analysis of trends over 40years. Arthritis Rheum 2003, 48:54-58.
8. Beavis P.A., Gregory B., Green P., Cribbs A.P., Kennedy A., Amjadi P., et al. Resistance to regulatory T cell-mediated suppression in rheumatoid arthritis can be bypassed by ectopic foxP3 expression in pathogenic synovial T cells. Proc Natl Acad Sci USA 2011, 108:16717-16722.
9. +CD25 high regulatory T cell population in peripheral blood. Rheumatology (Oxford) 2006, 45:1210-1217.
10. + T cells in the peripheral blood and synovial fluid of patients with rheumatoid arthritis. Scand J Immunol 2005, 62:312-317.
11. +CD25 high T cell numbers are enriched in the peripheral blood of patients with rheumatoid arthritis. Cell Immunol 2008, 253:92-101.
12. + regulatory T cells. Semin Immunol 2004, 16:89-97.
13. Van Amelsfort J.M., Jacobs K.M., Bijlsma J.W., Lafeber F.P., Taams L.S. CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum 2004, 50:2775-2785.
14. + regulatory T cells in autoimmune arthritis. Immunol Rev 2010, 233:97-111.
15. Chavele K.M., Ehrenstein M.R. Regulatory T-cells in systemic lupus erythematosus and rheumatoid arthritis. FEBS Lett 2011, 585:3603-3610.
16. +CD25 high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol 2007, 178:2579-2588.
17. + regulatory T cells in patients with systemic lupus erythematosus. Adv Exp Med Biol 2007, 601:113-119.
18. +) regulatory T cells in patients with systemic lupus erythematosus. Lupus 2007, 16:489-496.
19. -/low regulatory T cells in patients with active systemic lupus erythematosus. Arthritis Rheum 2008, 58:2120-2130.
20. Yates J., Whittington A., Mitchell P., Lechler R.I., Lightstone L., Lombardi G. Natural regulatory T cells: number and function are normal in the majority of patients with lupus nephritis. Clin Exp Immunol 2008, 153:44-55.
21. +CD127(low/-) T cells in patients with systemic lupus erythematosus. Zhonghua Yi Xue Za Zhi 2008, 88:453-456.
22. Bonelli M., Von Dalwigk K., Savitskaya A., Smolen J.S., Scheinecker C. FoxP3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis. Ann Rheum Dis 2008, 67:664-671.
23. + T cells in patients with new-onset systemic lupus erythematosus. Ann Rheum Dis 2008, 67:1037-1040.
24. Jury E.C., Flores-Borja F., Kalsi H.S., Lazarus M., Isenberg D.A., Mauri C., et al. Abnormal CTLA-4 function in T cells from patients with systemic lupus erythematosus. Eur J Immunol 2010, 40:569-578.
25. Aletaha D., Neogi T., Silman A.J., Funovits J., Felson D.T., Bingham C.O., et al. Rheumatoid arthritis classification criteria. An American college of rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum 2010, 62:2569-2581.
26. Prevoo M.L., Van't Hof M.A., Kuper H.H., Van Leeuwen M.A., Van de Putte L.B., Van Riel P.L. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995, 38:44-48.
27. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004, 22:531-562.
28. + regulatory T-cells. Nat Immunol 2003, 4:330-336.
29. Beyer M., Schultze J.L. Regulatory T cells in cancer. Blood 2006, 108:804-811.
30. Ryder L.R., Woetmann A., Madsen H.O., Ødum N., Ryder L.P., Bliddal H., et al. Expression of full-length and splice forms of FoxP3 in rheumatoid arthritis. Scand J Rheumatol 2010, 39:279-286.
31. Suzuki K., Setoyama Y., Yoshimoto K., Tsuzaka K., Abe T., Takeuchi T. Decreased mRNA expression of two FOXP3 isoforms in peripheral blood mononuclear cells from patients with rheumatoid arthritis and systemic lupus erythematosus. Int J Immunopathol Pharmacol 2011, 24:7-14.
32. Lin S.C., Chen K.H., Lin C.H., Kuo C.C., Ling Q.D., Chan C.H. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients. Eur J Clin Invest 2007, 37:987-996.
33. Sempere-Ortells J.M., Pérez-García V., Marín-Alberca G., Peris-Pertusa A., Benito J.M., Marco F.M., et al. Quantification and phenotype of regulatory T cells in rheumatoid arthritis according to disease activity score-28. Autoimmunity 2009, 42:636-645.
34. Oh J.S., Kim Y.G., Lee S.G., So M.W., Choi S.W., Lee C.K., et al. The effect of various disease-modifying anti-rheumatic drugs on the suppressive function of CD4(+)CD25(+) regulatory T cells. Rheumatol Int 2013, 33:381-388.
35. + regulatory T cells in the colon. J Immunol 2012, 15(189):2869-2878.